Early matrix metalloproteinase-12 inhibition worsens post-myocardial infarction cardiac dysfunction by delaying

Rugmani Padmanabhan Iyer1, Nicolle L Patterson2, Fouad A Zouein1

  • 1San Antonio Cardiovascular Proteomics Center, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA; Mississippi Center for Heart Research, Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA.

Abstract

Insights

Matrix metalloproteinase-12 (MMP-12) plays a protective role post-myocardial infarction by promoting neutrophil apoptosis. Inhibiting MMP-12 worsens left ventricular function by prolonging inflammation.

Area of Science:

  • Cardiovascular Biology
  • Enzymology
  • Immunology

Background:

  • Matrix metalloproteinases (MMPs) are crucial in regulating left ventricular (LV) remodeling after myocardial infarction (MI).
  • MMP-12 is known for its role in atherosclerotic plaque remodeling, but its specific functions post-MI were unexamined.
  • This study investigates the novel post-MI roles of MMP-12.

Purpose of the Study:

  • To elucidate the mechanisms of MMP-12 activity in the context of myocardial infarction.
  • To determine the cellular sources and functional consequences of MMP-12 expression post-MI.
  • To evaluate the therapeutic potential of MMP-12 inhibition in a mouse model of MI.

Main Methods:

  • Male C57BL/6J mice underwent left coronary artery ligation to induce MI.
  • Mice received either saline or an MMP-12 inhibitor (RXP 470.1) starting 3 hours post-MI.
  • Mice were analyzed at various time points (day 1, 3, 5, 7) post-MI, with comparisons to non-MI controls.

Main Results:

  • MMP-12 expression increased early post-MI, with neutrophils identified as a surprising cellular source.
  • MMP-12 inhibition led to increased LV dilation and worsened LV function, despite similar infarct sizes and survival rates.
  • Inhibition of MMP-12 impaired CD44-hyaluronan interactions, reduced neutrophil apoptosis, and prolonged pro-inflammatory cytokine upregulation.

Conclusions:

  • MMP-12 exhibits a novel protective function in neutrophil biology post-MI.
  • MMP-12 inhibition disrupts CD44-hyaluronan interactions, suppressing neutrophil apoptosis and exacerbating inflammation.
  • These findings highlight MMP-12 as a potential therapeutic target for improving cardiac function after MI.